Название продукции:2-Chloro-3-(trifluoromethyl)pyridine
IUPAC Name:2-chloro-3-(trifluoromethyl)pyridine
- CAS:65753-47-1
- Молекулярная формула:C6H3ClF3N
- Чистота:98%
- Номер в каталоге:CM120519
- Молекулярная масса:181.54
Только для использования в НИОКР..
Информация о продукции
- Номер CAS:65753-47-1
- Молекулярная формула:C6H3ClF3N
- Точка плавления:-
- Smiles-код:FC(C1=CC=CN=C1Cl)(F)F
- Плотность:
- Номер в каталоге:CM120519
- Молекулярная масса:181.54
- Точка кипения:
- Номер Mdl:MFCD00042223
- Хранение:
Category Infos
- Pyridines
- Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
- Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
- Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
- Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.
Column Infos
- Tavapadon
- Cerevel Therapeutics announces positive topline results for Tavapadon in phase 3 adjunctive trial for people living with Parkinson’s disease. The TEMPO-3 trial evaluated its efficacy, safety and tolerability met the primary endpoint and key secondary endpoint. The neurotransmitter dopamine is linked to working memory and motor movement, and the loss of dopamine-producing neurons in the brain result in Parkinson’s disease.
Tavapadon is a selective dopamine D1/D5 receptor partial agonist for the improved motor control. While most dopamine agonists target and stimulate D2/D3 dopamine receptors, Tavapadon is the only D1/D5 selective partial agonist in clinical development for PD.